Agarwal Nutan, Kriplani Alka, Gupta Anjali, Bhatla Neerja
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
J Reprod Med. 2002 Oct;47(10):871-4.
Gigantomastia during pregnancy is exceedingly rare, with an incidence of 1/28,000-100,000 pregnancies. Treatment during pregnancy is a dilemma, and postpartum reduction mammoplasty remains the mainstay of treatment.
Massive bilateral breast enlargement occurred at 19 weeks of gestation in a 24-year-old woman, gravida 2, and led to ulceration and sloughing. Conservative management with bromocriptine resulted in healing of the ulcers and resolution of symptoms. After six months of bromocriptine therapy postpartum, marked involution of the breasts occurred without recurrence.
Prolonged bromocriptine therapy should be given after delivery to a pregnant woman with gigantomastia during pregnancy before planning surgical reduction mammoplasty.
妊娠期巨乳症极为罕见,发生率为1/28,000至1/100,000次妊娠。孕期治疗是一个难题,产后缩乳术仍是主要的治疗方法。
一名24岁、孕2产0的女性在妊娠19周时出现双侧乳房巨大增大,并导致溃疡和脱落。使用溴隐亭进行保守治疗使溃疡愈合且症状缓解。产后溴隐亭治疗6个月后,乳房明显缩小且未复发。
对于孕期发生巨乳症的孕妇,在计划进行手术缩乳术前,产后应给予长时间的溴隐亭治疗。